Cargando…
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults
BACKGROUND & AIMS: Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the predominant liver cancers in children, though their respective treatment options and associated outcomes differ dramatically. Risk stratification using a combination of clinical, histological, and molecular paramet...
Autores principales: | Sumazin, Pavel, Peters, Tricia L., Sarabia, Stephen F., Kim, Hyunjae R., Urbicain, Martin, Hollingsworth, Emporia Faith, Alvarez, Karla R., Perez, Cintia R., Pozza, Alice, Najaf Panah, Mohammad Javad, Epps, Jessica L., Scorsone, Kathy, Zorman, Barry, Katzenstein, Howard, O’Neill, Allison F., Meyers, Rebecka, Tiao, Greg, Geller, Jim, Ranganathan, Sarangarajan, Rangaswami, Arun A., Woodfield, Sarah E., Goss, John A., Vasudevan, Sanjeev A., Heczey, Andras, Roy, Angshumoy, Fisher, Kevin E., Alaggio, Rita, Patel, Kalyani R., Finegold, Milton J., López-Terrada, Dolores H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524481/ https://www.ncbi.nlm.nih.gov/pubmed/35577029 http://dx.doi.org/10.1016/j.jhep.2022.04.035 |
Ejemplares similares
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells
por: Woodfield, Sarah E., et al.
Publicado: (2022) -
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2017) -
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children’s Hepatic Tumors International Collaboration (CHIC)
por: Trobaugh-Lotrario, Angela D., et al.
Publicado: (2023) -
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021) -
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021)